This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Enyo Pharma. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Jérôme Amaudrut: Innovator in Antiviral Compounds
Introduction
Jérôme Amaudrut is a notable inventor based in Dijon, France. He has made significant contributions to the field of antiviral agents through his innovative research and development. His work focuses on creating new classes of compounds that can effectively combat viral infections.
Latest Patents
Jérôme Amaudrut holds a patent for "Thiophene derivatives as antiviral agents." This invention relates to a new class of compounds that exhibit antiviral effects and outlines their various uses. His patent portfolio includes 1 patent that showcases his commitment to advancing antiviral therapies.
Career Highlights
Throughout his career, Jérôme has worked with prominent companies in the pharmaceutical industry. He has been associated with Enyo Pharma and AbbVie Inc., where he has contributed to the development of innovative treatments. His expertise in antiviral research has positioned him as a valuable asset in these organizations.
Collaborations
Jérôme has collaborated with several professionals in his field, including Eric Meldrum and Benoît De Chassey. These partnerships have enhanced his research efforts and contributed to the advancement of antiviral compounds.
Conclusion
Jérôme Amaudrut is a distinguished inventor whose work in antiviral agents has the potential to make a significant impact on public health. His innovative approach and dedication to research continue to drive advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile